$37,500 of AMGEN INC. lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to the pharmaceutical industry."
You can find more data on corporate lobbying on Quiver Quantitative.
AMGN Congressional Stock Trading
Members of Congress have traded $AMGN stock 6 times in the past 6 months. Of those trades, 3 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $AMGN stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 4 times. They made 2 purchases worth up to $30,000 on 06/05, 01/16 and 2 sales worth up to $30,000 on 02/26, 01/29.
- REPRESENTATIVE MARIA ELVIRA SALAZAR has traded it 2 times. They made 1 purchase worth up to $50,000 on 03/24 and 1 sale worth up to $50,000 on 04/17.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
AMGN Insider Trading Activity
AMGN insiders have traded $AMGN stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $AMGN stock by insiders over the last 6 months:
- ESTEBAN SANTOS (EVP, Operations) has made 0 purchases and 2 sales selling 54,792 shares for an estimated $20,772,595.
- NANCY A. GRYGIEL (SVP & CCO) sold 1,237 shares for an estimated $400,450
- MATTHEW C. BUSCH (VP, Finance & CAO) sold 1,000 shares for an estimated $375,790
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
AMGN Hedge Fund Activity
We have seen 1,254 institutional investors add shares of AMGN stock to their portfolio, and 1,264 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS removed 11,063,995 shares (-60.8%) from their portfolio in Q1 2026, for an estimated $3,892,866,640
- CAPITAL WORLD INVESTORS added 6,190,632 shares (+26.8%) to their portfolio in Q1 2026, for an estimated $2,178,173,869
- CAPITAL RESEARCH GLOBAL INVESTORS added 2,307,190 shares (+49.6%) to their portfolio in Q1 2026, for an estimated $811,784,801
- ROCKEFELLER CAPITAL MANAGEMENT L.P. removed 1,645,235 shares (-71.9%) from their portfolio in Q1 2026, for an estimated $578,875,934
- GEODE CAPITAL MANAGEMENT, LLC added 1,127,230 shares (+7.9%) to their portfolio in Q1 2026, for an estimated $396,615,875
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 962,341 shares (+8.1%) to their portfolio in Q1 2026, for an estimated $338,599,680
- UBS GROUP AG removed 956,484 shares (-23.3%) from their portfolio in Q1 2026, for an estimated $336,538,895
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
AMGN Price Targets
Multiple analysts have issued price targets for $AMGN recently. We have seen 15 analysts offer price targets for $AMGN in the last 6 months, with a median target of $350.0.
Here are some recent targets:
- Terence Flynn from Morgan Stanley set a target price of $333.0 on 07/08/2026
- Gregory Renza from Truist Securities set a target price of $340.0 on 07/07/2026
- Carter Gould from Cantor Fitzgerald set a target price of $350.0 on 07/06/2026
- Salim Syed from Mizuho set a target price of $303.0 on 06/16/2026
- David Amsellem from Piper Sandler set a target price of $427.0 on 05/14/2026
- Vamil Divan from Guggenheim set a target price of $340.0 on 05/04/2026
- Gary Nachman from Canaccord Genuity set a target price of $366.0 on 04/21/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
